chevron_leftBack
As of 5 June 2026, Biogena Group Invest AG has a market cap of $13.79M USD, ranking #39502 globally and #66 in Austria.
It ranks #3517 in the Healthcare sector, and #233 in the Drug Manufacturers - Specialty & Generic industry.
Key Stats
Market Cap
$13.79MUSD
11.89M EUR
Company Profile
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| 0.7% | -4% | -4.6% | -4% | -2.7% | 62% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
BIO
ISIN: ATBIOGENA005
|
3.00 EUR |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Biogena Group Invest AG
Biogena Group Invest AG engages in the provision of dietary supplements. The company is based in Salzburg, Austria.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
TLV: TEVA
|
$37.66B
273K%
108.92B ILS
|
24.2
|
|
NASDAQ: RVMD
|
$29.56B
214K%
|
-
|
|
SHE: 002001
|
$15.86B
115K%
107.34B CNY
|
16.0
|
|
NSE: CIPLA
|
$11.12B
81K%
1.06T INR
|
23.4
|
|
NSE: LUPIN
|
$11.0B
80K%
1.05T INR
|
22.7
|
|
SHE: 002653
|
$9.1B
66K%
61.6B CNY
|
80.6
|
chevron_leftBack